FWP
GILD icon

FAS Wealth Partners’s Gilead Sciences GILD Stock Holding History

FAS Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,840
Closed -$256K – 529
2026
Q1 		$256K Buy
+1,840
New +$258K 0.02% 310
2025
Q4 		– Sell
-1,172
Closed -$130K – 520
2025
Q3 		$130K Buy
+1,172
New +$133K 0.01% 328

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FAS Wealth Partners's GILD Position: Q2 2026 in Review

FAS Wealth Partners sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,840 shares — an estimated $256K sold.

FAS Wealth Partners first reported a position in GILD in Q3 2025 and held it in 2 quarters. The position peaked at $256K in Q1 2026. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • FAS Wealth Partners reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • FAS Wealth Partners sold 1,840 Gilead Sciences shares in Q2 2026, an estimated $256K.
  • FAS Wealth Partners first reported a position in Gilead Sciences in Q3 2025 and held it in 2 quarters.
  • FAS Wealth Partners's Gilead Sciences position peaked at $256K in Q1 2026.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on FAS Wealth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.